Form D — ALZpath, Inc.
0002145244-26-000001 · filed Jul 21, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $10,411,219
- Reported amount sold
- $8,411,219
- Minimum investment
- $0
- Investors
- 8
- Sales commission
- $0
- Finders' fees
- $125,000
Issuer
- Name
- ALZpath, Inc.
- CIK
- 2145244
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2292 FARDAY AVENUE
CARLSBAD, CA 92008 - Phone
- 617-645-2294
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Banville · Executive OfficerCarlsbad, CA Find on LinkedIn ↗
-
Jerre Stead · DirectorCarlsbad, CA Find on LinkedIn ↗
-
Harry Johns · DirectorCarlsbad, CA Find on LinkedIn ↗
-
John Courtney · DirectorCarlsbad, CA Find on LinkedIn ↗
-
John Hensing · DirectorCarlsbad, CA Find on LinkedIn ↗
-
Irit Rappley · DirectorCarlsbad, CA Find on LinkedIn ↗
-
Samantha Budd Haeberlein · DirectorCarlsbad, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗